CLINICAL AND FUNCTIONAL FEATURES OF HEART CONDITION IN PATIENTS WITH STABLE ANGINA WITH COMBINED CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Abstract
The article is devoted to the problem of combining chronic obstructive pulmonary disease (COPD) with coronary heart disease (CHD). Modern literature data on the prevalence of this combined pathology are presented. From the point of view of comorbidity its pathophysiological and clinical-functional features are considered. The peculiarities of clinical course and outcomes of the disease in patients with CHD associated with COPD are analyzed. CHD aggravates the course of COPD, increases right heart remodeling, diastolic dysfunction of right and left ventricles.
References
Hollingworth K, Müllerová H, Landis S, Aisanov Z, Davis K, Ichinose M
et al. Health behaviors and their correlates among participants in
the Continuing to Confront COPD International Patient Survey.
International Journal of Chronic Obstructive Pulmonary Disease.
;11:881–90. DOI: 10.2147/COPD.S102280
Miravitlles M, Roche N, Cardoso J, Halpin D, Aisanov Z, KankaanrantaH
et al. Chronic obstructive pulmonary disease guidelines in Europe:
a look into the future. Respiratory Research. 2018;19(1):11. DOI:
1186/s12931 018 0715 1
Ли В.В., Тимофеева Н.Ю., Задионченко В.С., Адашева Т.В.,12.
Высоцкая Н.В. Современные аспекты ремоделирования
сердца у больных хронической обструктивной болезнью
легких. Рациональная Фармакотерапия в Кардиологии.
;14(3):379-386. DOI: 10.20996/1819-6446-2018-14-3-
-386
Otakhanovich, B. N. T. Z. O., & Fayzullaevna, M. G. (2022). Effect of Combined Therapy of Atorvastatin with Milk Thistle Extract on the Functional State of the Liver in Patients with CHD.
Ayupovna, P. D. (2023). EVALUATION OF THE EFFECTIVENESS OF SIMULATION TRAINING IN TEACHING HEART AND LUNG AUSCULTATION.
Mirzaeva, G. P., Jabbarov, O. O., & Buvamuxamedova, N. T. (2022). FEATURES OF THE COURSE OF GOUTY KIDNEY DISEASE IN PATIENTS WITH OBESITY. Евразийский журнал медицинских и естественных наук, 2(13), 159-161.
Parpibaeva D. A., Buvamukhamedova N. T., Salaeva M. S., Boltaboev X. Q., & Turbanova U. V. (2023). CURRENT AND FUTURE APPROACHES TO THE DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE. Spectrum Journal of Innovation, Reforms and Development, 15, 310–318.
Buvamukhamedova Nasiba Takhirovna. (2023). Improving the Functional State of the Liver in Patients With Chd on the Background of Hypolipidemic Therapy. SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES, 2(11), 372–375.
Ayupovna, P. D., Saidabdullayevna, S. M., Djurabaevna, S. N., Shermuxamat o’g’li, E. N., & Taxirovna, B. N. (2023). FENOFIBRATE IN THE COMPLEX TREATMENT OF COMPLICATIONS OF TYPE 2 DIABETIC RETINOPATHY.
Parpibaeva, D. A., Buvamukhamedova, N. T., Ergashev, N. S., Salimova, N. D., & Salaeva, M. S. (2023). Optimization of Functional State of the Liver in Patients with Chd on the Background of Rosuvastatin Intake. Scholastic: Journal of Natural and Medical Education, 2(4), 8-12.
Жаббаров, А. А., Бувамухамедова, Н. Т., & Мирзаева, Г. Ф. (2021). ОЦЕНКА ФУНКЦИОНАЛЬНОГО СОСТОЯНИЯ ПЕЧЕНИ У БОЛЬНЫХ С ИБС НА ФОНЕ БАЗИСНОЙ ТЕРАПИИ В СОЧЕТАНИИ ЭКСТРАКТА РАСТОРОПШИ. Интернаука, (4-1), 34-36.
Buvamukhamedova, N. T., Jabbarov, O. O., Mirzayeva, G. F., & Madazimova, D. K. (2021). PROSPECTS OF RIVAROXABAN USE IN THE TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE. Oriental renaissance: Innovative, educational, natural and social sciences, 1(11), 496-502.
